Lotte Bjerre Knudsen is a big name in GLP-1 drug development, having helped invent the molecules that went on to become Novo Nordisk's obesity drugs Saxenda and Wegovy, among others. After a 36-year tenure at the Danish company, during which she won the Lasker and Breakthrough Prizes, she is to retire. The details are here.